A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1368-5031.2006.00903.x/fullpdf
Reference44 articles.
1. Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation - Regional and Global) project;Swales;Am Heart J,1999
2. 2003 European society of hypertension - European society of cardiology guidelines for the management of arterial hypertension;European society of hypertension - European society of cardiology guidelines;J Hypertens,2003
3. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report;Chobanian;JAMA,2003
4. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994;MacMahon;J Vasc Med Biol,1994
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03
2. Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis;The Journal of Clinical Hypertension;2021-02-20
3. Simultaneous Determination and Pharmacokinetics of Metolazone, Losartan and Losartan Carboxylic Acid in Rat Plasma by HPLC–ESI–MS-MS;Journal of Chromatographic Science;2015-05-06
4. Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis;European Heart Journal;2013-08-21
5. Using Primary Care Prescribing Databases to Determine Drug Switching and Continuation of Care;Basic & Clinical Pharmacology & Toxicology;2012-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3